Boan Biotech is Drug Discovery in China that focus on cell line development business. Founded in 2013. They cover business area such as operator, therapeutic antibody development, a focus, oncology, immunology, pain, endocrine, disease, antibody generation, lead optimization, cell line development, technology transfer, pilot production, commercial manufacturing, a presence, european and US market, safe and more affordable treat, patient.
2013
( 11 years old in 2024 )
Cell Line Development
-
39 Science and Technology Avenue
High-tech Zone
Yantai, Shandong
China
Private
operatortherapeutic antibody developmenta focusoncologyimmunologypainendocrinediseaseantibody generationlead optimizationcell line developmenttechnology transferpilot productioncommercial manufacturinga presenceeuropean and US marketsafe and more affordable treatpatient
* We use standard office opening hours in near Boan Biotech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Boan Biotech is Drug Discovery business from China that founded in 2013 (11 years old in 2024), Boan Biotech business is focusing on Cell Line Development.
Boan Biotech headquarter office and corporate office address is located in 39 Science and Technology Avenue High-tech Zone Yantai, Shandong China.
Boan Biotech was founded in China.
In 2024, Boan Biotech is currently focus on cell line development sector.
Above is snippet of Google Trends for "cell line development" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Boan Biotech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
